Accendra Health filed a prospectus for a $200M mixed shelf offering. The filing was submitted to the United States Securities and Exchange Commission (SEC). This registration statement allows the company to offer and sell debt securities, common stock, preferred stock, and warrants.

The mixed shelf offering enables Accendra Health to raise capital flexibly. Securities may be sold in one or more offerings at prices to be determined at the time of sale. The company intends to use the net proceeds for general corporate purposes, which may include working capital, capital expenditures, and potential acquisitions.

The prospectus is available on the SEC's website. J.P. Morgan Securities LLC and BofA Securities Inc. are listed as the underwriters for the offering. No specific timing for the sale of securities has been announced yet.

Offering Details

The filing provides Accendra Health the ability to access capital markets as opportunities arise. The actual amount and timing of any securities sales will depend on market conditions and the company's capital requirements.

Accendra Health, Inc. has successfully concluded its exchange offers for outstanding debt, with holders tendering approximately 99.9% of the aggregate principal amount of its 4.500% Senior Notes due 2029 and 99.2% of its 6.625% Senior Notes due 2030. The exchange offers expired at 5:00 P.M., New York City time, on June 23, 2026. This transaction allows the company to restructure its debt obligations by issuing new notes in exchange for the existing ones.

Epiq Corporate Restructuring, LLC reported that valid and unwithdrawn tenders represented approximately $478.3 million in aggregate principal amount of 2029 Notes and $548.0 million in aggregate principal amount of 2030 Notes. The company's obligation to accept these notes for exchange is subject to the satisfaction or waiver of conditions outlined in the Offering Memorandum dated May 22, 2026.

Exchange Details

In connection with the exchange offers, Accendra Health issued or expects to issue new securities to the eligible holders. The total issuance includes new notes provided in exchange for the tendered existing notes as well as proceeds from a new money issuance.

Regulatory and Advisory Roles

The offering of the new notes has not been registered with the Securities and Exchange Commission (SEC) under the Securities Act of 1933. The exchange offers were made exclusively to Eligible Holders, defined as qualified institutional buyers relying on Rule 144A or non-U.S. persons relying on Regulation S.

Epiq Corporate Restructuring, LLC served as the Exchange Agent and Information Agent for the offers and consent solicitations. Ducera Securities LLC acted as the financial advisor for the transaction. The company stated that this press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.